Literature DB >> 28025408

A case of anti aquapolin-4 antibody positive myelitis with hyperhidrosis, following herpes zoster.

Machiko Suda1, Michiko Tsutsumiuchi, Yoshikazu Uesaka, Nobukazu Hayashi.   

Abstract

We report an acute myelitis in a 53-year-old woman that occurred in 7 days after the diagnosis of Th5-6 herpes zoster. Clinical examination revealed hyperhidrosis of left side of her face, neck, arm and upper chest. She also had muscle weakness of her left leg and sensory impairment for light touch and temperature in her chest and legs. Spinal cord MRI demonstrated a longitudinal T2-hyperintense lesion extending from Th1 to 7. In the axial imaging, the lesion dominantly located in the left side gray matter. Hyperhidrosis, weakness and sensory impairment were improved after intravenous therapy with acyclovir and methylprednisolone. VZV (varicella zoster virus) IgG index of the cerebrospinal fluid was high and serological anti aquaporin-4 antibodies were positive at the time of the admission. This case had both characteristics of VZV myelitis and neuromyelitis optica spectrum disorder. Myelitis relapsed 19 months after the first attack. We believe that sympathetic hyper reactivity due to thoracic spinal cord lesion was responsible for the hyperhidrosis in our patient.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28025408     DOI: 10.5692/clinicalneurol.cn-000820

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  Herpes Zoster Radiculomyelitis With Aquaporin-4 Antibodies: A Case Report and Literature Review.

Authors:  Hiroto Eguchi; Haruka Takeshige; Sho Nakajima; Masayoshi Kanou; Asuka Nakajima; Atsuto Fuse; Jiro Fukae; Hideto Miwa; Yasushi Shimo
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

2.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association.

Authors:  Franziska Di Pauli; Paul Morschewsky; Klaus Berek; Michael Auer; Angelika Bauer; Thomas Berger; Gabriel Bsteh; Paul Rhomberg; Kathrin Schanda; Anne Zinganell; Florian Deisenhammer; Markus Reindl; Harald Hegen
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.